Wells Fargo’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-116
Closed -$28K 7279
2021
Q2
$28K Sell
116
-30,497
-100% -$6.95M ﹤0.01% 5777
2021
Q1
$6.71M Buy
30,613
+28,052
+1,095% +$5.63M ﹤0.01% 2552
2020
Q4
$12K Buy
2,561
+1,630
+175% +$282K ﹤0.01% 5983
2020
Q3
$4K Sell
931
-1,513
-62% -$240K ﹤0.01% 6048
2020
Q2
$5K Buy
+2,444
New +$338K ﹤0.01% 5976

Other funds holding LH

Wells Fargo's LH Position: Q1 2026 in Review

Wells Fargo increased its Labcorp (LH) stake by 5.9% in Q1 2026, buying an estimated $4.87M and bringing the position to 321,411 shares worth $85.8M. The position accounts for 0.02% of the portfolio, ranked #697.

Wells Fargo first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $160M in Q3 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Wells Fargo held 321,411 shares of Labcorp worth $85.8M as of Q1 2026.
  • Wells Fargo bought 17,977 Labcorp shares in Q1 2026, an estimated $4.87M.
  • Labcorp made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #697 holding.
  • Wells Fargo first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Labcorp position peaked at $160M in Q3 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.